New pill aims to improve blood flow in lungs for patients with rare disease
Disease control
Recruiting now
This study tests a new drug called mirivadelgat in 126 adults with pulmonary hypertension linked to interstitial lung disease (PH-ILD). The drug aims to improve blood flow in the lungs, exercise ability, and heart function. Participants take a capsule daily for 12 weeks and have …
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 06, 2026 16:14 UTC